Successful At-Home Use of the Tandem Control-IQ Artificial Pancreas System in Young Children During a Randomized Controlled Trial

Objective: Hybrid closed-loop (HCL) artificial pancreas (AP) systems are now moving from research settings to widespread clinical use. In this study, the inControl algorithm developed by TypeZero Technologies was embedded to a commercial Tandem t:slim X2 insulin pump, now called Control-IQ, paired w...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Diabetes Technol Ther
Auteurs principaux: Forlenza, Gregory P., Ekhlaspour, Laya, Breton, Marc, Maahs, David M., Wadwa, R. Paul, DeBoer, Mark, Messer, Laurel H., Town, Marissa, Pinnata, Jennifer, Kruse, Geoff, Buckingham, Bruce A., Cherñavvsky, Daniel
Format: Artigo
Langue:Inglês
Publié: Mary Ann Liebert, Inc., publishers 2019
Sujets:
Original Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6909715/
https://ncbi.nlm.nih.gov/pubmed/30888835
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dia.2019.0011
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires